Bio-Rad Laboratories, Inc. (BIO) financial statements (2022 and earlier)

Company profile

Business Address 1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
State of Incorp. DE
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8701,3371,1611,0209911,1541,032
Cash and cash equivalents471860733673662840608
Short-term investments399477429346329314424
Restricted cash and investments6666666
Receivables424418399408419402363
Inventory, net of allowances, customer advances and progress billings572589599605622640628
Inventory572589599605622640628
Prepaid expense1081051111109111192
Other current assets1012132611105
Other undisclosed current assets      7
Total current assets:1,9892,4662,2892,1752,1402,3242,133
Noncurrent Assets
Operating lease, right-of-use asset205204190196202197198
Property, plant and equipment491   491  
Long-term investments and receivables14,38716,23111,58010,5039,5618,4406,703
Long-term investments14,38716,23111,58010,5039,5618,4406,703
Intangible assets, net (including goodwill)601469477484491497503
Goodwill347292292292292292292
Intangible assets, net (excluding goodwill)254177185192199205211
Other noncurrent assets103   87  
Other undisclosed noncurrent assets 583581575 563561
Total noncurrent assets:15,78717,48712,82811,75810,8339,6977,965
TOTAL ASSETS:17,77619,95315,11813,93312,97312,02110,097
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities465434395402420365188
Accounts payable142136133138139133 
Employee-related liabilities277244209175223190156
Taxes payable46545289574232
Deferred revenue51   42  
Debt12224427427
Deferred compensation liability4      
Other liabilities128178155166131161147
Other undisclosed current liabilities323636393434165
Total current liabilities:681650587610632987927
Noncurrent Liabilities
Long-term debt and lease obligation, including:1118717517912184185
Long-term debt, excluding current maturities 111111 1212
Finance lease, liability11   11  
Operating lease, liability176177164168175172173
Other undisclosed long-term debt and lease obligation(176)   (174)  
Liabilities, other than long-term debt3,3153,7842,7612,5352,3692,0251,632
Deferred income tax liabilities3,0593,5692,5422,3062,0771,8431,457
Liability, pension and other postretirement and postemployment benefits74   95  
Other liabilities182214219229197182175
Other undisclosed noncurrent liabilities102   80  
Total noncurrent liabilities:3,4283,9712,9362,7142,4612,2091,817
Total liabilities:4,1094,6213,5233,3243,0933,1962,744
Stockholders' equity
Stockholders' equity attributable to parent, including:13,66715,33211,59510,6099,8808,8257,353
Additional paid in capital442421460445429412429
Accumulated other comprehensive income (loss)(176)(63)1256828284(61)
Retained earnings13,50715,08111,15910,2459,2688,4297,123
Other undisclosed stockholders' equity attributable to parent(106)(107)(149)(150)(100)(100)(138)
Total stockholders' equity:13,66715,33211,59510,6099,8808,8257,353
TOTAL LIABILITIES AND EQUITY:17,77619,95315,11813,93312,97312,02110,097

Income statement (P&L) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues733747716727790647537
Cost of revenue
(Cost of Goods and Services Sold)
(332)(310)(314)(326)(330)(280)(244)
Other undisclosed gross profit0   0  
Gross profit:401437402401460367293
Operating expenses(294)(281)(277)(300)(285)(258)(241)
Operating income:10715712510117511052
Nonoperating income (expense)8(3)2174016
Foreign currency transaction gain (loss), before tax(2)(2)2(0)1(1)(1)
Other nonoperating income (expense)10(1)(0)173117
Interest and debt expense(0)(0)(0)(0)(5)(6)(6)
Other undisclosed income from continuing operations before equity method investments, income taxes  1,0311,1799041,5801,183
Income from continuing operations before equity method investments, income taxes:1141541,1571,2971,0791,6841,246
Other undisclosed income (loss) from continuing operations before income taxes(2,153)4,869     
Income (loss) from continuing operations before income taxes:(2,038)5,0221,1571,2971,0791,6841,246
Income tax expense (benefit)464(1,094)(243)(320)(239)(370)(280)
Net income (loss) available to common stockholders, diluted:(1,574)3,9289149778391,315966

Comprehensive Income ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net income (loss):(1,574)3,9289149778391,315966
Other comprehensive income (loss)(113)(188)57(214)19814588
Comprehensive income (loss), net of tax, attributable to parent:(1,686)3,7409717631,0381,4601,054

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: